K O S PHARMACEUTICALS INC
KOSP
KOSP was delisted on the 14th of December, 2006.
2 hedge funds and large institutions have $629K invested in K O S PHARMACEUTICALS INC in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 0 reducing their positions, and 0 closing their positions.
100% more funds holding
Funds holding: 1 → 2 (+1)
80% less capital invested
Capital invested by funds: $3.09M → $629K (-$2.46M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TVWM
Tower View Wealth Management
Shorewood,
Wisconsin
|
+$175K |
Top Sellers
KOSP Hedge Fund Activity: Q2 2023 in Review
2 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in K O S PHARMACEUTICALS INC (KOSP) for Q2 2023, worth a combined $629K — down 80% from $3.09M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new KOSP positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Tower View Wealth Management, opening a new position worth an estimated $175K.
- 2 institutional investors held K O S PHARMACEUTICALS INC (KOSP) as of Q2 2023, up from 1 in Q1 2023.
- Funds reported $629K of K O S PHARMACEUTICALS INC stock for Q2 2023, down 80% quarter-over-quarter.
- 2 funds opened new K O S PHARMACEUTICALS INC positions in Q2 2023 and 0 closed out, a net change of +2 holders.
- The largest K O S PHARMACEUTICALS INC buyer in Q2 2023 was Tower View Wealth Management, an estimated $175K added.
Based on aggregated 13F filings for Q2 2023.